Literature DB >> 14726699

Activation of CDK4 gene expression in human breast cancer cells by the Brn-3b POU family transcription factor.

Laila Samady1, Jonathan Dennis, Vishwanie Budhram-Mahadeo, David S Latchman.   

Abstract

The Brn-3b POU family transcription factor has previously been shown to be over-expressed in human breast cancer and to enhance the growth rate and anchorage independent growth of human breast cancer cells, acting at least in part by inhibiting the expression of the BRCA-1 anti-oncogene. Here we have used gene arrays to identify several other targets for Brn-3b in human breast cancer cells, including cyclin-dependent kinase 4 (CDK4). In particular, we show that levels of CDK4 mRNA and protein correlate with the levels of Brn-3b in breast cancer cell lines manipulated to express different levels of Brn-3b and in human breast cancer biopsies and that Brn-3b can activate the CDK4 promoter. The effect of Brn-3b on the growth regulatory CDK4 protein provides a further mechanism by which Brn-3b can regulate breast cancer cell growth and indicates that it can do this by activating as well as repressing specific target genes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14726699

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  16 in total

1.  Hsp-27 induction requires POU4F2/Brn-3b TF in doxorubicin-treated breast cancer cells, whereas phosphorylation alters its cellular localisation following drug treatment.

Authors:  Rieko Fujita; Samir Ounzain; Alice Chun Yin Wang; Richard John Heads; Vishwanie Shanie Budhram-Mahadeo
Journal:  Cell Stress Chaperones       Date:  2011-01-29       Impact factor: 3.667

2.  Multiple roles of cyclin-dependent kinase 4/6 inhibitors in cancer therapy.

Authors:  Patrick J Roberts; John E Bisi; Jay C Strum; Austin J Combest; David B Darr; Jerry E Usary; William C Zamboni; Kwok-Kin Wong; Charles M Perou; Norman E Sharpless
Journal:  J Natl Cancer Inst       Date:  2012-02-01       Impact factor: 13.506

3.  Cdk2-null mice are resistant to ErbB-2-induced mammary tumorigenesis.

Authors:  Dipankar Ray; Yasuhisa Terao; Konstantin Christov; Philipp Kaldis; Hiroaki Kiyokawa
Journal:  Neoplasia       Date:  2011-05       Impact factor: 5.715

4.  Cancer-related transcriptional targets of the circadian gene NPAS2 identified by genome-wide ChIP-on-chip analysis.

Authors:  Chun-Hui Yi; Tongzhang Zheng; Derek Leaderer; Aaron Hoffman; Yong Zhu
Journal:  Cancer Lett       Date:  2009-05-19       Impact factor: 8.679

5.  Proliferation-associated POU4F2/Brn-3b transcription factor expression is regulated by oestrogen through ERα and growth factors via MAPK pathway.

Authors:  Samir Ounzain; Samantha Bowen; Chandrakant Patel; Rieko Fujita; Richard J Heads; Vishwanie S Budhram-Mahadeo
Journal:  Breast Cancer Res       Date:  2011-01-17       Impact factor: 6.466

6.  Boswellia sacra essential oil induces tumor cell-specific apoptosis and suppresses tumor aggressiveness in cultured human breast cancer cells.

Authors:  Mahmoud M Suhail; Weijuan Wu; Amy Cao; Fadee G Mondalek; Kar-Ming Fung; Pin-Tsen Shih; Yu-Ting Fang; Cole Woolley; Gary Young; Hsueh-Kung Lin
Journal:  BMC Complement Altern Med       Date:  2011-12-15       Impact factor: 3.659

7.  Direct inhibition of the DNA-binding activity of POU transcription factors Pit-1 and Brn-3 by selective binding of a phenyl-furan-benzimidazole dication.

Authors:  Paul Peixoto; Yang Liu; Sabine Depauw; Marie-Paule Hildebrand; David W Boykin; Christian Bailly; W David Wilson; Marie-Hélène David-Cordonnier
Journal:  Nucleic Acids Res       Date:  2008-04-25       Impact factor: 16.971

8.  A critical role for ATF2 transcription factor in the regulation of E-selectin expression in response to non-endotoxin components of Neisseria meningitidis.

Authors:  M C Jacobsen; P J Dusart; K Kotowicz; M Bajaj-Elliott; S L Hart; N J Klein; G L Dixon
Journal:  Cell Microbiol       Date:  2015-07-31       Impact factor: 3.715

9.  Profound hyperglycemia in knockout mutant mice identifies novel function for POU4F2/Brn-3b in regulating metabolic processes.

Authors:  Stavroula Bitsi; Houda Ali; Lauren Maskell; Samir Ounzain; Vidya Mohamed-Ali; Vishwanie S Budhram-Mahadeo
Journal:  Am J Physiol Endocrinol Metab       Date:  2015-12-15       Impact factor: 4.310

10.  Brn-3b enhances the pro-apoptotic effects of p53 but not its induction of cell cycle arrest by cooperating in trans-activation of bax expression.

Authors:  Vishwanie S Budhram-Mahadeo; Samantha Bowen; Sonia Lee; Christina Perez-Sanchez; Elizabeth Ensor; Peter J Morris; David S Latchman
Journal:  Nucleic Acids Res       Date:  2006-12-01       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.